Brexit's lessons for Alberta

Since last week, there have been a series of alarming bits of news emerging from Siberia. It began with the mysterious death of a woman who worked at a plague research institute. Russia has said she contracted pneumonia but has been slim on details. But the World Health Organizat ...  Show more

With the election of the Parti Québécois in Quebec Monday night, it's the first time in twelve years that Canada will have a separatist government in power. Over the course of the campaign, the party's leader, Paul St-Pierre Plamondon, made clear some of the fights he could take ...  Show more

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ...  Show more

UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ...  Show more

American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ...  Show more

Researchers in Germany say they've identified what could be behind the reports of blood clotting in people who have had the AstraZeneca coronavirus vaccine. The German team - in yet to be released pre-print research - say that the vaccine could in rare circumstances cause an auto ...  Show more